Fedorchenko SV, Klimenko Z, Martynovich T, Solianyk I, et al. Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks. J Virol 2025 Jan 22:e0184324. doi: 10.1128/jvi.01843.
PMID: 39840947